| scholarly article | Q13442814 |
| P2093 | author name string | Qian Jiang | |
| Pin Zhang | |||
| Zhi-Yuan Zhang | |||
| Dong-Xia Ye | |||
| Hong-Ya Pan | |||
| Sdek Patima | |||
| P2860 | cites work | Beta2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells | Q24631263 |
| Beta-2 microglobulin in ESRD: an in-depth review | Q28235019 | ||
| beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis | Q28264292 | ||
| Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma | Q33356953 | ||
| Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. | Q35675358 | ||
| Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression | Q35786324 | ||
| Anti beta2-microglobulin monoclonal antibodies induce apoptosis in myeloma cells by recruiting MHC class I to and excluding growth and survival cytokine receptors from lipid rafts | Q36059640 | ||
| Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma | Q36151380 | ||
| Overexpression of beta2-microglobulin is associated with poor survival in patients with oral cavity squamous cell carcinoma and contributes to oral cancer cell migration and invasion | Q36965088 | ||
| Recent advances in Oral Oncology 2007: imaging, treatment and treatment outcomes | Q37080402 | ||
| Beta2-microglobulin: emerging as a promising cancer therapeutic target. | Q37341252 | ||
| beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma. | Q37383437 | ||
| Efficient recovery of HLA class I expression in human tumor cells after beta2-microglobulin gene transfer using adenoviral vector: implications for cancer immunotherapy | Q39821151 | ||
| Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma. | Q40009864 | ||
| Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. | Q40152757 | ||
| Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies | Q40219619 | ||
| Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7. | Q40309412 | ||
| Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma | Q43257891 | ||
| Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate. | Q46039290 | ||
| beta-catenin expression pattern in primary oral squamous cell carcinoma | Q46532976 | ||
| The prognostic significance of serum beta2 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1,180 patients | Q46775262 | ||
| Modification of beta-2-microglobulin in sera from patients with small cell lung cancer: evidence for involvement of a serine protease | Q70186656 | ||
| The significance of soluble interleukin-2, soluble interleukin-2 receptors, soluble ICAM-1 and beta 2-microglobulin in breast cancer patients | Q72002733 | ||
| HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas | Q73078335 | ||
| Beta-2-microglobulin (beta 2M) as a tumor marker in nasopharyngeal carcinoma | Q73505346 | ||
| Beta 2-microglobulin-deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism | Q73873443 | ||
| Beta2-microglobulin-deficient NK cells show increased sensitivity to MHC class I-mediated inhibition, but self tolerance does not depend upon target cell expression of H-2Kb and Db heavy chains | Q74251738 | ||
| Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis | Q79451522 | ||
| Beta2 microglobulin: a surprising therapeutic target for prostate cancer and renal cell carcinoma | Q80489377 | ||
| High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis | Q80550726 | ||
| Gastrointestinal beta2microglobulin amyloidosis in hemodialysis patients: biochemical analysis of amyloid proteins in small formalin-fixed paraffin-embedded tissue specimens | Q81419905 | ||
| Induction of antitumor immunity by CTL epitopes genetically linked to membrane-anchored beta2-microglobulin | Q81645797 | ||
| Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease | Q82871930 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 1058-1064 | |
| P577 | publication date | 2011-12-30 | |
| P1433 | published in | Oncology Reports | Q7092098 |
| P1476 | title | Upregulation of β2-microglobulin expression in progressive human oral squamous cell carcinoma | |
| P478 | volume | 27 |
Search more.